Verdot

Status
Current portfolio
Investment type
Growth Buy-out
Investment date
July 2022
Location
France

Headquartered in Riom (France), Verdot has established itself, over its 20-year history, as a leading, independent biomanufacturing tools company. Specialized in the design, manufacturing and installation of custom-made industrial purification equipment, its target end markets are the Biotech, Pharmaceutical, Veterinary and Food industries. The company is focused on Low-Pressure Liquid Chromatography (LPLC) devices that play a key role in the manufacturing and development of complex biologic molecules including monoclonal antibodies, vaccines, and gene therapies.

Backed by strong, in-house scientific, technological and regulatory know-how, the company took a decisive, strategic turn several years ago when it chose to develop and market innovative, single-use chromatography equipment. Thanks to a solid network of clients made up of the largest pharmaceutical and biotechnology groups, Verdot is well established internationally, particularly in the United States, where it generates almost half of its revenue.

Our relationship with Lauxera, built on robust mutual trust, has been a strong asset in developing a growth strategy, strengthening our global leadership, reinforcing our presence in North America, Europe and Asia. What we value most about Lauxera is their hands on attitude, the seniority of their leadership, the deep knowledge of the biopharma industry and their extensive network.

Charles RubanCEO at Verdot

I am very impressed by Verdot’s positioning and strong growth over the last few years. Verdot has world-class technical know-how and decades of experience enabling the company to support clients on very specific needs. Verdot’s willingness to go deep with customers is unique in the market. Lauxera will support Verdot’s international commercialization efforts while bolstering its industrial capabilities.

Pierre MoustialCo-founding Partner at Lauxera
Acandis

Acandis

Neurovascular medical devices — Lauxera Growth II
Antaros Medical

Antaros Medical

Imaging drug development — Lauxera Growth II
BioLamina

BioLamina

Regenerative medicine tools — Lauxera Growth I
Caresyntax

Caresyntax

Surgical intelligence platform — Lauxera Growth I
Lifen

Lifen

Digital health integration — Lauxera Growth I
LUMICKS

LUMICKS

Protein and cell analysis — Lauxera Growth I
Matrix One

Matrix One

Medtech compliance platform — Lauxera Growth I
Natural Cycles

Natural Cycles

Non-hormonal contraception — Lauxera Growth I
OrganOx

OrganOx

Liver transplant optimization — Lauxera Growth I
Ospi

Ospi

Healthtech data intelligence — Lauxera Growth I
Reapplix

Reapplix

Advanced wound care — Lauxera Growth I
Synovo Group

Synovo Group

Patient transportation software — Lauxera Growth I
Veranex

Veranex

Medtech innovation services — Lauxera Growth I